Khiron Life Sciences Corp. (KHRNF)

0.0001 0.0000 (0.00%) At close: 04:00PM EDT

Khiron Life Sciences Corp.

500 Burrard Street
Suite 2300
Vancouver, BC
Canada
647 556-5750
https://khiron.ca

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Alvaro Francisco Torres	Co-Founder, CEO & Director	202.95k	N/A	1979
Ms. Franziska Katterbach	President of Khiron Europe	286.76k	N/A	N/A
Mr. Swapan Kakumanu ACA, ACWA, CGA	Corporate Secretary	44.61k	N/A	1969
Mr. Michael John O'Connor MA	Chief Financial Officer	N/A	N/A	1967
Mr. Manuel Buendia	Vice President of Operations	N/A	N/A	N/A
Mr. Marco Algorta	Country Manager of Uruguay	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Corporate Governance

Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.